Related Experiment Videos
Christine Lodberg Hvas1,2, Åse Bengård Andersen3, Kirsten Møller4
1Intensiv, Aarhus Universitetshospital.
Abstract:
Acute bacterial meningitis (ABM) is associated with increased intracranial pressure (ICP) caused by bacterial invasion and the host response to infection. Antibiotic therapy is a sine qua non, and adjunct dexamethasone decreases mortality. The ICP increase may have a rapid course and death due to herniation is most often seen within the first week. Evidence regarding treatment of increased ICP in ABM is limited; this review summarises observational studies which point towards reduced mortality by applying a structured approach towards normalization of ICP in ABM.
Insights
Acute bacterial meningitis (ABM) can rapidly increase intracranial pressure (ICP). A structured approach to normalizing ICP in ABM, guided by observational studies, may reduce mortality.
Area of Science:
- Neurology
- Infectious Diseases
- Critical Care Medicine
Background:
- Acute bacterial meningitis (ABM) frequently causes elevated intracranial pressure (ICP) due to infection and host inflammatory responses.
- Rapidly increasing ICP in ABM can lead to herniation and death, often within the first week of illness.
- Current evidence for managing increased ICP specifically in ABM is limited.
Approach:
- This review synthesizes findings from observational studies investigating ICP management in ABM.
- The focus is on a structured approach aimed at normalizing ICP levels.
- The analysis considers the impact of ICP normalization on patient outcomes.
Key Points:
- Elevated ICP is a critical complication of ABM, driven by bacterial factors and the immune response.
- Prompt antibiotic treatment and dexamethasone are crucial for reducing mortality in ABM.
- Observational data suggest that actively managing and normalizing ICP can improve survival rates.
Conclusions:
- A systematic strategy for ICP management in ABM is supported by current evidence.
- Reducing mortality in ABM may be achieved through targeted ICP normalization.
- Further research is warranted to establish definitive guidelines for ICP treatment in ABM.